Genetix raises $35m to deliver gene therapy | AltAssets Private Equity News

Subscribe today

Advanced
Search

Genetix raises $35m to deliver gene therapy

12 Mar 2010

Genetix Pharmaceuticals has completed a $35m series B financing, with new investors Third Rock Ventures and Genzyme Ventures joining TVM Capital, Forbion and Easton Capital.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.